The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Chloro-N-[6-(2-ethyl-5-fluoro-4-hydroxy-phenyl)-1H-indazol-4-yl]benzenesulfonamide ID: ALA4560212
PubChem CID: 155558352
Max Phase: Preclinical
Molecular Formula: C21H17ClFN3O3S
Molecular Weight: 445.90
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCc1cc(O)c(F)cc1-c1cc(NS(=O)(=O)c2ccccc2Cl)c2cn[nH]c2c1
Standard InChI: InChI=1S/C21H17ClFN3O3S/c1-2-12-9-20(27)17(23)10-14(12)13-7-18-15(11-24-25-18)19(8-13)26-30(28,29)21-6-4-3-5-16(21)22/h3-11,26-27H,2H2,1H3,(H,24,25)
Standard InChI Key: VPIZBXRPGLRGBT-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
34.8214 -20.7476 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.6109 -21.5400 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.4024 -21.3261 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.9049 -20.3169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6146 -19.9075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6117 -19.0848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9031 -18.6795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3149 -18.6748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0244 -19.0825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7301 -18.6719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7275 -17.8538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0132 -17.4481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3105 -17.8610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1969 -19.9079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1981 -19.0869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4176 -18.8319 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.9339 -19.4955 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4156 -20.1604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9047 -21.1341 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.4331 -17.4416 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.6121 -22.3600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0267 -19.8997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0073 -16.6309 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.7355 -20.3063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9021 -22.7668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9029 -23.5861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6142 -23.9959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3262 -23.5804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3218 -22.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0269 -22.3493 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
14 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 15 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 8 2 0
6 8 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 2 0
18 14 1 0
4 19 1 0
19 2 1 0
11 20 1 0
2 21 1 0
9 22 1 0
12 23 1 0
22 24 1 0
21 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 21 1 0
29 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 445.90Molecular Weight (Monoisotopic): 445.0663AlogP: 5.09#Rotatable Bonds: 5Polar Surface Area: 95.08Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 6.71CX Basic pKa: 2.03CX LogP: 4.83CX LogD: 4.22Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.40Np Likeness Score: -1.53
References 1. Ritzén A, Sørensen MD, Dack KN, Greve DR, Jerre A, Carnerup MA, Rytved KA, Bagger-Bahnsen J.. (2016) Fragment-Based Discovery of 6-Arylindazole JAK Inhibitors., 7 (6): [PMID:27326341 ] [10.1021/acsmedchemlett.6b00087 ]